Tourniquet vs. no Tourniquet During Total Knee Arthroplasty

Rothman Institute Orthopaedics1 site in 1 countryJune 1, 2016

Overview

The purpose of this study is to correlate functional outcomes and perioperative complications with tourniquet use during total knee arthroplasty.

Registry

clinicaltrials.gov

Start Date

June 1, 2016

End Date

October 1, 2017

Last Updated

6 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Sponsor

Responsible Party

Sponsor

•All unilateral primary knee arthroplasties performed by investigators participating in this study will be eligible for inclusion
•Diagnosis of osteoarthritis

•Revision surgery
•Bilateral knee surgery
•Age \<18 or \>80
•Baseline lower extremity strength less than 5/5
•Vascular calcifications
•History of chronic narcotic use, defined as more than 5mg of oxycodone q4 hours
•Functionally limiting spine disease
•Other functionally limiting lower extremity disorder (i.e. symptomatic ipsilateral hip disease)
•Patients who cannot perform the baseline functional tests
•Allergy/contraindication to protocol medications

timed up and go (TUG) score

Time Frame: 4 weeks following surgery

Stair Climb test

Time Frame: in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op

time, in seconds, to climb one flight of nine stairs

Visual Analog Scale: Pain

Time Frame: in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op

surgical field visualization(intra-operative)
blood loss(intra-operative)
range of motion(in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op)